SKIP TO CONTENT
30+/SKIN
← BRANDSPRODUCTS 1MEAN SCORE 80ONLINE DERMATOLOGY · PHARMACY CHOICE

Miiskin

Miiskin makes the choice between a conventional pharmacy prescription and a custom compound visible. The useful comparison starts after the visit fee, when the exact medicine and pharmacy quote are known.

MODEL

Independent clinician assessment, followed by a separately purchased prescription when appropriate.

AGGREGATE
MEAN SCORE80
/ 100
PRODUCTS REVIEWED1
SCORE RANGE80 – 80
PRICINGSEE EACH OFFER AND BILLING PERIOD BELOW
MEAN DISCLOSURE80 / 100
RECOMMENDED0
CONDITIONAL1
CAUTION0
AVOID0
01

The brand verdict

1 PRODUCTS ASSESSED

This profile covers the published tretinoin-access route. Its strongest feature is the ability to discuss dispensing options before committing to a medication subscription. That is useful flexibility, without proving better clinical outcomes.

A consultation fee, a renewal fee and a medication price answer different questions. Ask for each over the same treatment period. The single service review supports a finding about this route's disclosure, not a judgment about every clinician in the network.

WHAT THEY GET RIGHT
  • Distinguishes medication from consultation pricing.
  • Explains the existence of both conventional and compounded routes.
02

The range

RANKED BY SCORE
03

What the reviewed offering tells us

2 PATTERNS

This profile covers one offering. These findings describe its published terms and do not establish a pattern across the company's entire catalogue.

04

Disclosure scorecard

WHAT EACH PAGE TELLS YOU

Not what is in the product — what the company publishes about it, and where. “Findable” means the concentration exists somewhere, such as a help-centre article, rather than on the page you buy from.

SCROLL THE TABLE SIDEWAYS

PRODUCTVISIT FEEPHARMACY CHOICEMEDICINE INCLUDED
Online DermatologyPARTYESNO
05

Reviewed offering

PARTIAL SCORES · SEE EACH REVIEW'S SCOPE
HIGHEST SCORING

Online Dermatology

80CONDITIONAL

Worth buying for a specific person with a specific problem. Read who.

BRAND RECORD
REVIEW SCOPETRETINOIN ACCESS · NOT THE WHOLE CATALOGUE
RESEARCH CHECKED13 SEPTEMBER 2026
METHODPUBLIC-SOURCE DESK REVIEW
SCORE SCOPEDISCLOSURE ONLY · 15% OF MODEL
BRAND PAGES SUMMARISE OUR PUBLISHED REVIEWS. EVERY FACTUAL CLAIM ABOUT A PRODUCT IS SOURCED IN THE REVIEW IT COMES FROM. SCORES ARE FINALISED BEFORE ANY COMMERCIAL LINK IS ATTACHED.

Sources

  1. S-01Miiskin — requesting tretinoin online

    Consultation and renewal fees, pharmacy choice, generic and compounded options. Checked 13 September 2026.

  2. S-02FDA — understanding compounded-drug risks

    Compounded preparations do not undergo FDA premarket review for safety, effectiveness or quality; they can meet individual medical needs. Checked 13 September 2026.

THE DRAW · NO. 01

Win a year of
prescription skincare

One reader gets a 12 months CoreAge Rx derm plan — the compounded, physician-reviewed subscription we take apart in the register. Worth $780. Leave an address and you are entered.

PRIZE
12 MONTHS OF COREAGE RX
VALUE
$780 — $64.99/MO × 12
ENTRY
ONE EMAIL ADDRESS

VALUE IS THE PUBLISHED $64.99/MONTH SUBSCRIPTION PRICE OVER TWELVE MONTHS, AS RECORDED IN R-10. NO PURCHASE NECESSARY. WE REVIEW COREAGE RX — WE DO NOT SELL IT.

DEPTH 000%
THE DRAW · ONE READER

Win a year of
prescription skincare

One reader gets a 12 months CoreAge Rx derm subscription — compounded, physician-reviewed, delivered. See the product records in our review register.

VALUE$780
TERM12 MONTHS$64.99/MO × 12

VALUE IS THE PUBLISHED $64.99/MONTH SUBSCRIPTION PRICE OVER TWELVE MONTHS, AS RECORDED IN R-10. NO PURCHASE NECESSARY. WE REVIEW COREAGE RX — WE DO NOT SELL IT.